Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin

Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706 · see citing works

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326 · see citing works

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260 · see citing works

Humoral Immunity Due to Long-Lived Plasma Cells

Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249 · see citing works

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203 · see citing works

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Sui, J., Hwang, W. C., Perez, S., Ge, W., Aird, D. R., Chen, L., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,132 · see citing works

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036 · see citing works

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026 · see citing works

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 867 · see citing works

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777 · see citing works

Cutting edge: long-term B cell memory in humans after smallpox vaccination

Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695 · see citing works

Are We Ready for Pandemic Influenza?

Webby, R. J., & Webster, R. G. (2003) · Science · doi:10.1126/science.1090350 · Cited by 659 · see citing works

Broadly Neutralizing Antiviral Antibodies

Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 469 · see citing works

Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies

Gerhard, W., Yewdell, J. W., Frankel, M. E., & Webster, R. G. (1981) · Nature · doi:10.1038/290713a0 · Cited by 460 · see citing works

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 448 · see citing works

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Zatta, F., Santos, C. P., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 433 · see citing works

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

Krammer, F., Pica, N., Hai, R., Margine, I., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.00641-13 · Cited by 425 · see citing works

Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system

Crotty, S., Aubert, R. D., Glidewell, J., & Ahmed, R. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2003.12.015 · Cited by 421 · see citing works

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393 · see citing works

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

Khurana, S., Chearwae, W., Castellino, F., Manischewitz, J. F., King, L. R., Honorkiewicz, A., Rock, M. T., Edwards, K. M., Giudice, G. D., Rappuoli, R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000624 · Cited by 268 · see citing works

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

Kashyap, A. K., Steel, J., Öner, A. F., Dillon, M. A., Swale, R. E., Wall, K. M., Perry, K. J., Faynboym, A. M., Ilhan, M. M., Horowitz, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801367105 · Cited by 252 · see citing works

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

Pica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T. M., Stein, C. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200039109 · Cited by 251 · see citing works

Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages

Whittle, J. R. R., Wheatley, A. K., Wu, L., Lingwood, D., Kanekiyo, M., Steven, S., Narpala, S., Yassine, H. M., Frank, G. M., Yewdell, J. W., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03422-13 · Cited by 250 · see citing works

Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

Khurana, S., Loving, C. L., Manischewitz, J. F., King, L. R., Gauger, P. C., Henningson, J. N., Vincent, A. L., & Golding, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006366 · Cited by 224 · see citing works

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

Lu, Y., Welsh, J. P., & Swartz, J. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308701110 · Cited by 216 · see citing works

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

Ledgerwood, J. E., Wei, C., Hu, Z., Gordon, I. J., Enama, M. E., Hendel, C. S., McTamney, P. M., Pearce, M. B., Yassine, H. M., Boyington, J. C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70240-7 · Cited by 188 · see citing works

Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization

Brandenburg, B., Koudstaal, W., Goudsmit, J., Klaren, V., Tang, C., Bujny, M. V., Korse, H. J. W. M., Kwaks, T., Otterstrom, J., Juraszek, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080034 · Cited by 166 · see citing works

A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum EfficacyIn Vivo

Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161 · see citing works

Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

Nabel, G. J., & Fauci, A. S. (2010) · Nature Medicine · doi:10.1038/nm1210-1389 · Cited by 152 · see citing works

Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies

Sui, J., Sheehan, J., Hwang, W. C., Bankston, L. A., Burchett, S. K., Huang, C.-Y., Liddington, R., Beigel, J. H., & Marasco, W. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir121 · Cited by 129 · see citing works

Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies

Harris, A. K., Meyerson, J. R., Matsuoka, Y., Kuybeda, O., Moran, A., Bliss, D., Das, S. R., Yewdell, J. W., Sapiro, G., Subbarao, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214913110 · Cited by 110 · see citing works

Influenza vaccines

Ellebedy, A. H., & Webby, R. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.038 · Cited by 105 · see citing works

Seasonal influenza and vaccination coverage

Monto, A. S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.027 · Cited by 87 · see citing works

VACCINATION AGAINST INFLUENZA

FRANCIS, T. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72235-5 · Cited by 78 · see citing works

Influenza: Options to Improve Pandemic Preparation

Rappuoli, R., & Dormitzer, P. R. (2012) · Science · doi:10.1126/science.1221466 · Cited by 75 · see citing works

Universal influenza virus vaccines: need for clinical trials

Krammer, F., & Palese, P. (2013) · Nature Immunology · doi:10.1038/ni.2761 · Cited by 70 · see citing works

Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant

Belshe, R. B., Frey, S. E., Graham, I., Mulligan, M. J., Edupuganti, S., Jackson, L. A., Wald, A., Poland, G., Jacobson, R., Keyserling, H. L., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq093 · Cited by 62 · see citing works

Re-Engaging Cross-Reactive Memory B Cells: The Influenza Puzzle

Ellebedy, A. H., & Ahmed, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00053 · Cited by 55 · see citing works

[Vaccination against influenza].

Przesmycki, F., Walkowska, E., Dobrowolska, H., Zych, Z., Feltynowski, A., Przybyłkiewicz, Z., & Zanski, J. (1954) · PubMed · Cited by 38 · see citing works

Viva la revolución: rethinking influenza A virus antigenic drift

Yewdell, J. W. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.05.005 · Cited by 35 · see citing works

Flexibility in humans

Kugelberg, E. (2014) · Nature reviews. Immunology · doi:10.1038/nri3797 · Cited by 5 · see citing works

The human antibody response to influenza A virus infection and vaccination

Krammer, F. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 805 · see citing works

Advances in the development of influenza virus vaccines

Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592 · see citing works

Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting

Gostic, K. M., Ambrose, M. R., Worobey, M., & Lloyd‐Smith, J. O. (2016) · Science · doi:10.1126/science.aag1322 · Cited by 464 · see citing works

Immune history profoundly affects broadly protective B cell responses to influenza

Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Henry, C., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 413 · see citing works

Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting

Mesin, L., Schiepers, A., Ersching, J., Barbulescu, A., Cavazzoni, C. B., Angelini, A., Okada, T., Kurosaki, T., & Victora, G. D. (2019) · Cell · doi:10.1016/j.cell.2019.11.032 · Cited by 355 · see citing works

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nachbagauer, R., Feser, J., Naficy, A. B., Bernstein, D. I., Guptill, J. T., Walter, E. B., Berlanda-Scorza, F., Stadlbauer, D., Wilson, P. C., Aydillo, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1118-7 · Cited by 340 · see citing works

Next-generation influenza vaccines: opportunities and challenges

Wei, C., Crank, M. C., Shiver, J. W., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 324 · see citing works

Quadrivalent influenza nanoparticle vaccines induce broad protection

Boyoglu-Barnum, S., Ellis, D., Gillespie, R. A., Hutchinson, G. B., Park, Y., Moin, S. M., Acton, O. J., Ravichandran, R., Murphy, M., Pettie, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03365-x · Cited by 306 · see citing works

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Lee, J., Boutz, D. R., Chromikova, V., Joyce, M. G., Vollmers, C., Leung, K., Horton, A. P., DeKosky, B. J., Lee, C., Lavinder, J. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4224 · Cited by 278 · see citing works

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.003 · Cited by 262 · see citing works

Towards a universal influenza vaccine: different approaches for one goal

Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 202 · see citing works

Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses

Zhang, A., Stacey, H. D., Mullarkey, C. E., & Miller, M. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801149 · Cited by 195 · see citing works

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 180 · see citing works

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Houser, K. V., Chen, G. L., Carter, C., Crank, M. C., Nguyen, T., Florez, M. C. B., Berkowitz, N. M., Mendoza, F. H., Hendel, C. S., Gordon, I. J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01660-8 · Cited by 165 · see citing works

Is a Universal Influenza Virus Vaccine Possible?

Nachbagauer, R., & Palese, P. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-120617-041310 · Cited by 159 · see citing works

How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin

Doud, M. B., Lee, J. M., & Bloom, J. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03665-3 · Cited by 158 · see citing works

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans

Nachbagauer, R., Choi, A., Izikson, R., Cox, M. M. J., Palese, P., & Krammer, F. (2016) · mBio · doi:10.1128/mbio.01996-15 · Cited by 149 · see citing works

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

Corbett, K. S., Moin, S. M., Yassine, H. M., Cagigi, A., Kanekiyo, M., Boyoglu-Barnum, S., Myers, S. I., Tsybovsky, Y., Wheatley, A. K., Schramm, C. A., et al. (2019) · mBio · doi:10.1128/mbio.02810-18 · Cited by 146 · see citing works

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

Nachbagauer, R., Liu, W., Choi, A., Wohlbold, T. J., Atlas, T., Rajendran, M., Solórzano, A., Scorza, F. B., García‐Sastre, A., Palese, P., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0026-4 · Cited by 137 · see citing works

Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection

Kaku, C. I., Bergeron, A. J., Ahlm, C., Normark, J., Sakharkar, M., Forsell, M. N. E., & Walker, L. M. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq3511 · Cited by 131 · see citing works

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses

Goff, P. H., Hayashi, T., Martínez‐Gil, L., Corr, M., Crain, B., Yao, S., Cottam, H. B., Chan, M., Ramos, I., Eggink, D., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03337-14 · Cited by 119 · see citing works

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner

Mullarkey, C. E., Bailey, M. J., Golubeva, D., Tan, G. S., Nachbagauer, R., He, W., Novakowski, K. E., Bowdish, D. M. E., Miller, M. S., & Palese, P. (2016) · mBio · doi:10.1128/mbio.01624-16 · Cited by 115 · see citing works

The aryl hydrocarbon receptor controls cell-fate decisions in B cells

Vaidyanathan, B., Chaudhry, A., Yewdell, W. T., Angeletti, D., Yen, W.-F., Wheatley, A. K., Bradfield, C. A., McDermott, A. B., Yewdell, J. W., Rudensky, A. Y., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160789 · Cited by 111 · see citing works

Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza

Zarnitsyna, V. I., Lavine, J. S., Ellebedy, A. H., Ahmed, R., & Antia, R. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005692 · Cited by 105 · see citing works

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem

Tan, H., Jegaskanda, S., Juno, J. A., Esterbauer, R., Wong, J., Kelly, H. G., Liu, Y., Tilmanis, D., Hurt, A. C., Yewdell, J. W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123366 · Cited by 105 · see citing works

Novel universal influenza virus vaccine approaches

Krammer, F. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.02.002 · Cited by 99 · see citing works

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

Yin, Q., Luo, W., Mallajosyula, V. V. A., Yang, B., Guo, J., Xie, J., Sun, M., Verma, R., Li, C., Constantz, C. M., et al. (2023) · Nature Materials · doi:10.1038/s41563-022-01464-2 · Cited by 100 · see citing works

H5N1 Vaccine–Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem

Wheatley, A. K., Whittle, J. R. R., Lingwood, D., Kanekiyo, M., Yassine, H. M., Steven, S., Narpala, S., Prabhakaran, M. S., Matus‐Nicodemos, R., Bailer, R. T., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402835 · Cited by 98 · see citing works

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Widge, A. T., Hofstetter, A. R., Houser, K. V., Awan, S. F., Chen, G. L., Florez, M. C. B., Berkowitz, N. M., Mendoza, F. H., Hendel, C. S., Holman, L. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4790 · Cited by 97 · see citing works

Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods

Vrdoljak, A., Allen, E. A., Ferrara, F., Temperton, N. J., Crean, A. M., & Moore, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.019 · Cited by 95 · see citing works

Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses

Guthmiller, J. J., Lan, L. Y.-L., Fernández‐Quintero, M. L., Han, J., Utset, H. A., Bitar, D. J., Hamel, N. J., Stovicek, O., Li, L., Tepora, M. E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.005 · Cited by 93 · see citing works

Original Antigenic Sin: How Original? How Sinful?Preprint

Yewdell, J. W., & Santos, J. J. D. S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038786 · Cited by 93 · see citing works

Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage

Angeletti, D., & Yewdell, J. W. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.008 · Cited by 92 · see citing works

Germinal Center Selection and the Antibody Response to Influenza

Victora, G. D., & Wilson, P. C. (2015) · Cell · doi:10.1016/j.cell.2015.10.004 · Cited by 91 · see citing works

Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Neu, K. E., Henry, C., & Wilson, P. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.012 · Cited by 87 · see citing works

Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine

Coughlan, L., & Palese, P. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.016 · Cited by 85 · see citing works

Emerging influenza viruses and the prospect of a universal influenza virus vaccine

Krammer, F. (2015) · Biotechnology Journal · doi:10.1002/biot.201400393 · Cited by 85 · see citing works

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

Ellebedy, A. H., Nachbagauer, R., Jackson, K., Dai, Y.-N., Han, J., Alsoussi, W. B., Davis, C. W., Stadlbauer, D., Rouphael, N., Chromikova, V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906613117 · Cited by 83 · see citing works

Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza

Zarnitsyna, V. I., Ellebedy, A. H., Davis, C. W., Jacob, J., Ahmed, R., & Antia, R. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0248 · Cited by 82 · see citing works

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

Wohlbold, T. J., Nachbagauer, R., Margine, I., Tan, G. S., Hirsh, A., & Krammer, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.038 · Cited by 82 · see citing works

First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

Guthmiller, J. J., Han, J., Li, L., Freyn, A. W., Liu, S. T. H., Stovicek, O., Stamper, C. T., Dugan, H. L., Tepora, M. E., Utset, H. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg4535 · Cited by 77 · see citing works

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

Andrews, S. F., Cominsky, L. Y., Shimberg, G. D., Gillespie, R. A., Gorman, J., Raab, J. E., Brand, J., Creanga, A., Gajjala, S. R., Narpala, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4976 · Cited by 77 · see citing works

Antibody modulation of B cell responses—Incorporating positive and negative feedback

Cyster, J. G., & Wilson, P. C. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.009 · Cited by 77 · see citing works

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

Vanderven, H. A., Ana‐Sosa‐Batiz, F., Jegaskanda, S., Rockman, S. P., Laurie, K., Barr, I., Chen, W., Wines, B. D., Hogarth, P. M., Lambe, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.029 · Cited by 76 · see citing works

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

Jacobsen, H., Rajendran, M., Choi, A., Sjursen, H., Brokstad, K. A., Cox, R. J., Palese, P., Krammer, F., & Nachbagauer, R. (2017) · mBio · doi:10.1128/mbio.01463-17 · Cited by 73 · see citing works

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

Abreu, R. B., Kirchenbaum, G. A., Clutter, E. F., Sautto, G. A., & Ross, T. M. (2019) · JCI Insight · doi:10.1172/jci.insight.132155 · Cited by 71 · see citing works

Imprinting, immunodominance, and other impediments to generating broad influenza immunity

Knight, M., Changrob, S., Li, L., & Wilson, P. C. (2020) · Immunological Reviews · doi:10.1111/imr.12900 · Cited by 69 · see citing works

Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination

Han, J., Schmitz, A. J., Richey, S. T., Dai, Y.-N., Turner, H. L., Mohammed, B. M., Fremont, D. H., Ellebedy, A. H., & Ward, A. B. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108682 · Cited by 61 · see citing works

Harnessing immune history to combat influenza viruses

Guthmiller, J. J., & Wilson, P. C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.010 · Cited by 61 · see citing works

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Bajic, G., van der Poel, C. E., Kuraoka, M., Schmidt, A. G., Carroll, M. C., Kelsoe, G. H., & Harrison, S. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40175-8 · Cited by 60 · see citing works

How a well-adapting immune system remembers

Mayer, A., Balasubramanian, V., Walczak, A. M., & Mora, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812810116 · Cited by 54 · see citing works

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

Liu, W., Nachbagauer, R., Stadlbauer, D., Solórzano, A., Scorza, F. B., García‐Sastre, A., Palese, P., Krammer, F., & Albrecht, R. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00756 · Cited by 57 · see citing works

Bringing immunofocusing into focus

Musunuri, S., Weidenbacher, P. A. B., & Kim, P. S. (2024) · npj Vaccines · doi:10.1038/s41541-023-00792-x · Cited by 48 · see citing works

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies

Nakajima, R., Supnet, M., Jasinskas, A., Jain, A., Taghavian, O., Obiero, J. M., Milton, D. K., Chen, W. H., Grantham, M. L., Webby, R. J., et al. (2018) · mSphere · doi:10.1128/msphere.00592-18 · Cited by 52 · see citing works

Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response

Nguyen, P. Q. T., Sangster, M. Y., & Topham, D. J. (2021) · Pathogens · doi:10.3390/pathogens10030355 · Cited by 52 · see citing works

B Cell Response to Vaccination

Luo, W., & Yin, Q. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1903033 · Cited by 52 · see citing works

B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

Guthmiller, J. J., Utset, H. A., & Wilson, P. C. (2021) · Viruses · doi:10.3390/v13060965 · Cited by 52 · see citing works

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

Tesini, B. L., Kanagaiah, P., Wang, J., Hahn, M. A., Halliley, J. L., Chaves, F. A., Nguyen, P. Q. T., Nogales, A., DeDiego, M. L., Anderson, C., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00169-19 · Cited by 51 · see citing works

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head

Wiersma, L., Rimmelzwaan, G. F., & de Vries, R. D. (2015) · Vaccines · doi:10.3390/vaccines3020239 · Cited by 48 · see citing works

Immune history shapes human antibody responses to H5N1 influenza viruses

Garretson, T. A., Liu, J., Li, S. H., Scher, G., Santos, J. J. D. S., Hogan, G. E., Vieira, M. C., Furey, C., Atkinson, R. K., Ye, N., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03599-6 · Cited by 48 · see citing works

Seasonality in risk of pandemic influenza emergence

Fox, S. J., Miller, J. C., & Ancel, L. W. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005749 · Cited by 47 · see citing works

High-Affinity H7 Head and Stalk Domain–Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine

Halliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45 · see citing works

Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine

Cho, A., & Wrammert, J. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.002 · Cited by 45 · see citing works

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic

Gagnon, A., Acosta, E., Hallman, S., Bourbeau, R. R., Dillon, L., Ouellette, N., Earn, D. J. D., Herring, D. A., Inwood, K. E., Madrenas, J., et al. (2018) · mBio · doi:10.1128/mbio.02091-17 · Cited by 45 · see citing works

Requirement for memory B-cell activation in protection from heterologous influenza virus reinfection

Leach, S., Shinnakasu, R., Adachi, Y., Momota, M., Makino‐Okamura, C., Yamamoto, T., Ishii, K. J., Fukuyama, H., Takahashi, Y., & Kurosaki, T. (2019) · International Immunology · doi:10.1093/intimm/dxz049 · Cited by 45 · see citing works

Controlled Human Infection Models To Accelerate Vaccine Development

Choy, R. K. M., Bourgeois, A. L., Ockenhouse, C. F., Walker, R. I., Sheets, R., & Flores, J. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-21 · Cited by 44 · see citing works

Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies

Kirchenbaum, G. A., Carter, D. M., & Ross, T. M. (2015) · Journal of Virology · doi:10.1128/jvi.02372-15 · Cited by 44 · see citing works

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Andrews, S. F., Raab, J. E., Gorman, J., Gillespie, R. A., Cheung, C. S. F., Rawi, R., Cominsky, L. Y., Boyington, J. C., Creanga, A., Shen, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01636-8 · Cited by 43 · see citing works

Next-Generation Influenza VaccinesPreprint

Kanekiyo, M., & Graham, B. S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038448 · Cited by 40 · see citing works

Strategies to induce broadly protective antibody responses to viral glycoproteins

Krammer, F. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1299576 · Cited by 41 · see citing works

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

Stadlbauer, D., Rajabhathor, A., Amanat, F., Kaplan, D., Masud, A., Treanor, J. J., Izikson, R., Cox, M. M. J., Nachbagauer, R., & Krammer, F. (2017) · mSphere · doi:10.1128/msphere.00502-17 · Cited by 41 · see citing works

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

Pushko, P., & Tretyakova, I. (2020) · Viruses · doi:10.3390/v12050518 · Cited by 40 · see citing works

Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains

Ryder, A. B., Nachbagauer, R., Buonocore, L., Palese, P., Krammer, F., & Rose, J. K. (2015) · Journal of Virology · doi:10.1128/jvi.02598-15 · Cited by 39 · see citing works

Development of next generation hemagglutinin-based broadly protective influenza virus vaccines

Nachbagauer, R., & Palese, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.001 · Cited by 39 · see citing works

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin

Николаевна, И.-С. И., Korenkov, D. A., Smolonogina, T. A., Kotomina, T. S., Donina, S., Matyushenko, V., Mezhenskaya, D. А., Krammer, F., & Георгиевна, Р. Л. (2018) · Virology · doi:10.1016/j.virol.2018.03.013 · Cited by 38 · see citing works

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

Nachbagauer, R., Shore, D. A., Yang, H., Johnson, S. K., Gabbard, J. D., Tompkins, S. M., Wrammert, J., Wilson, P. C., Stevens, J., Ahmed, R., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00949-18 · Cited by 38 · see citing works

T and B Cell Immune Responses to Influenza Viruses in Pigs

Holzer, B., Martini, V., Edmans, M. D., & Tchilian, E. Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00098 · Cited by 38 · see citing works

The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains

Nienen, M., Stervbo, U., Mölder, F., Kaliszczyk, S., Kuchenbecker, L., Gayova, L., Schweiger, B., Jürchott, K., Hecht, J., Neumann, A. U., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00593 · Cited by 37 · see citing works

Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay

He, W., Mullarkey, C. E., & Miller, M. S. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.037 · Cited by 35 · see citing works

Inactivated influenza virus vaccines: the future of TIV and QIV

Schotsaert, M., & García‐Sastre, A. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.04.005 · Cited by 33 · see citing works

Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses

Sage, V. L., Jones, J. E., Kormuth, K. A., Fitzsimmons, W. J., Nturibi, E. M., Padovani, G. H., Arevalo, C. P., French, A. J., Avery, A. J., Manivanh, R. V., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009273 · Cited by 34 · see citing works

Vaccination against rapidly evolving pathogens and the entanglements of memory

Cobey, S. E. (2024) · Nature Immunology · doi:10.1038/s41590-024-01970-2 · Cited by 35 · see citing works

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza

Wang, J., Hilchey, S. P., Hyrien, O., Huertas, N., Perry, S., Manojkumar, R., Bucher, D. J., & Zand, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129858 · Cited by 32 · see citing works

Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses

Zheng, D., Chen, S., Qu, D., Chen, J., Wang, F., Zhang, R., & Chen, Z. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.026 · Cited by 32 · see citing works

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Demminger, D. E., Walz, L., Dietert, K., Hoffmann, H., Planz, O., Gruber, A. D., von Messling, V., & Wolff, T. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910938 · Cited by 32 · see citing works

The Next Generation of Influenza Vaccines: Towards a Universal Solution

McMillan, C. L. D., Young, P. R., Watterson, D., & Chappell, K. J. (2021) · Vaccines · doi:10.3390/vaccines9010026 · Cited by 32 · see citing works

Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccinesPreprint

Boyoglu-Barnum, S., Ellis, D., Gillespie, R. A., Hutchinson, G. B., Park, Y., Moin, S. M., Acton, O. J., Ravichandran, R., Murphy, M., Pettie, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.30.125179 · Cited by 32 · see citing works

Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets

Hay, J. A., Laurie, K., White, M. T., & Riley, S. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007294 · Cited by 29 · see citing works

Influenza virus antigenicity and broadly neutralizing epitopes

Air, G. M. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.03.006 · Cited by 30 · see citing works

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity

Sato-Kaneko, F., Yao, S., Lao, F. S., Shpigelman, J., Messer, K. S., Pu, M., Shukla, N. M., Cottam, H. B., Chan, M. D., Chu, P. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01207 · Cited by 30 · see citing works

Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines

Sangesland, M., & Lingwood, D. (2021) · Vaccines · doi:10.3390/vaccines9020125 · Cited by 34 · see citing works

Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

Spangler, A., Shimberg, G. D., Mantus, G. E., Malek, R., Cominsky, L. Y., Tsybovsky, Y., Li, N., Gillespie, R. A., Ravichandran, M., Creanga, A., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.004 · Cited by 29 · see citing works

Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice

van der Lubbe, J. E. M., Verspuij, J. W. A., Huizingh, J., Schmit-Tillemans, S. P. R., Tolboom, J. T. B. M., Dekking, L., Kwaks, T., Brandenburg, B., Meijberg, W., Zahn, R. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02350 · Cited by 29 · see citing works

Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance

Mathew, N. R., & Angeletti, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02997 · Cited by 29 · see citing works

Infection of Ferrets with Influenza Virus Elicits a Light Chain–Biased Antibody Response against Hemagglutinin

Kirchenbaum, G. A., Allen, J. D., Layman, T. S., Sautto, G. A., & Ross, T. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701174 · Cited by 28 · see citing works

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

Nachbagauer, R., Salaun, B., Stadlbauer, D., Behzadi, M. A., Friel, D., Rajabhathor, A., Choi, A., Albrecht, R. A., Debois, M., García‐Sastre, A., et al. (2019) · npj Vaccines · doi:10.1038/s41541-019-0147-z · Cited by 28 · see citing works

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

Goll, J. B., Jain, A., Jensen, T. L., de Assis, R., Nakajima, R., Jasinskas, A., Coughlan, L., Cherikh, S. R., Gelber, C. E., Khan, S., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00524-7 · Cited by 28 · see citing works

A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells

Luque, S., Lúcia, M., Crespo, E., Jarque, M., Grinyo, J. M., & Bestard, O. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.07.011 · Cited by 28 · see citing works

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components

Hernandez‐Davies, J. E., Felgner, J. H., Strohmeier, S., Pone, E. J., Jain, A., Jan, S., Nakajima, R., Jasinskas, A., Strahsburger, E., Krammer, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692151 · Cited by 26 · see citing works

Inducing broad-based immunity against viruses with pandemic potential

Sette, A., & Saphire, E. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.010 · Cited by 24 · see citing works

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393 · see citing works

Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

Wei, C., Boyington, J. C., McTamney, P. M., Kong, W., Pearce, M. B., Xu, L., Andersen, H., Rao, S. S., Tumpey, T. M., Yang, Z., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337 · see citing works

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Andrews, S. F., Raab, J. E., Gorman, J., Gillespie, R. A., Cheung, C. S. F., Rawi, R., Cominsky, L. Y., Boyington, J. C., Creanga, A., Shen, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01636-8 · Cited by 43 · see citing works

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

Andrews, S. F., Cominsky, L. Y., Shimberg, G. D., Gillespie, R. A., Gorman, J., Raab, J. E., Brand, J., Creanga, A., Gajjala, S. R., Narpala, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4976 · Cited by 77 · see citing works

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

Thomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 109 · see citing works